Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
AHCO 
Adapthealth Corp (AHCO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: AHCO (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $13.12
1 Year Target Price $13.12
| 5 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -75.38% | Avg. Invested days 21 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.25B USD | Price to earnings Ratio 17.07 | 1Y Target Price 13.12 |
Price to earnings Ratio 17.07 | 1Y Target Price 13.12 | ||
Volume (30-day avg) 8 | Beta 1.59 | 52 Weeks Range 7.11 - 11.70 | Updated Date 09/17/2025 |
52 Weeks Range 7.11 - 11.70 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.54 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.49% | Operating Margin (TTM) 7.1% |
Management Effectiveness
Return on Assets (TTM) 3.7% | Return on Equity (TTM) 5.51% |
Valuation
Trailing PE 17.07 | Forward PE 7.92 | Enterprise Value 3128944411 | Price to Sales(TTM) 0.38 |
Enterprise Value 3128944411 | Price to Sales(TTM) 0.38 | ||
Enterprise Value to Revenue 0.96 | Enterprise Value to EBITDA 4.91 | Shares Outstanding 135298000 | Shares Floating 89446763 |
Shares Outstanding 135298000 | Shares Floating 89446763 | ||
Percent Insiders 8.13 | Percent Institutions 105.09 |
Upturn AI SWOT
Adapthealth Corp
Company Overview
History and Background
AdaptHealth Corp. was formed in 2012 and has grown through acquisitions to become a leading provider of home medical equipment (HME) and related services. They focus on providing a full suite of medical equipment, supplies, and related services for individuals at home.
Core Business Areas
- Home Medical Equipment (HME): Provides a wide range of medical equipment for home use, including oxygen equipment, sleep therapy equipment, mobility equipment, and other medical supplies.
- Respiratory Therapy: Offers respiratory therapy services, including oxygen therapy, sleep apnea treatment, and ventilation support.
- Diabetes Care: Provides continuous glucose monitors (CGMs) and related supplies to individuals with diabetes.
Leadership and Structure
The leadership team includes Stephen Griggs (CEO). The organizational structure is based on functional departments and regional operations.
Top Products and Market Share
Key Offerings
- Sleep Therapy Equipment (CPAP/BiPAP): Provides CPAP and BiPAP machines, masks, and accessories for treating sleep apnea. The CPAP market is highly competitive, with ResMed and Philips Respironics being major competitors. AdaptHealth has a significant market share in this segment, estimated at around 15-20% based on total industry revenues.
- Oxygen Therapy Equipment: Offers oxygen concentrators, portable oxygen systems, and related supplies. Competitors include Lincare and Apria Healthcare. Market Share is about 10% based on total industry revenues
- Continuous Glucose Monitors (CGMs): Supplies CGMs and related supplies from manufacturers like Dexcom and Abbott. Competitors include Edgepark Medical Supplies and Byram Healthcare. Market share is estimated at between 5%-10%.
Market Dynamics
Industry Overview
The HME industry is experiencing growth due to an aging population, increasing prevalence of chronic diseases, and a shift towards home-based healthcare.
Positioning
AdaptHealth is a leading player in the HME market, focusing on acquiring and integrating smaller HME providers to expand its geographic reach and service offerings. The company is known for its focus on patient care and compliance.
Total Addressable Market (TAM)
The global home healthcare market is expected to reach hundreds of billions of dollars. AdaptHealth is positioned to capture a significant portion of this TAM through strategic acquisitions and organic growth.
Upturn SWOT Analysis
Strengths
- Large and diversified product portfolio
- Strong acquisition track record
- Extensive geographic reach
- Focus on patient care and compliance
- Established relationships with manufacturers and payers
Weaknesses
- Integration risks associated with acquisitions
- Exposure to reimbursement pressures
- High debt levels
- Dependence on government regulations
- Competition from larger players
Opportunities
- Further acquisitions of smaller HME providers
- Expansion into new geographic markets
- Development of new products and services
- Growth in the home healthcare market
- Increased demand for telehealth solutions
Threats
- Changes in reimbursement policies
- Increased competition
- Rising operating costs
- Economic downturn
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- RESM
- PGNY
- LHCG
Competitive Landscape
AdaptHealth's advantages include its scale and geographic reach. Disadvantages include its high debt levels and integration risks.
Major Acquisitions
Reliant at Home
- Year: 2021
- Acquisition Price (USD millions): 445
- Strategic Rationale: Expanded AdaptHealth's presence in the Southeast and strengthened its respiratory product offerings.
Growth Trajectory and Initiatives
Historical Growth: AdaptHealth has experienced rapid growth through acquisitions over the past several years.
Future Projections: Analyst projections indicate continued revenue growth, with improvements in profitability as integration efforts progress.
Recent Initiatives: Recent strategic initiatives include acquisitions of smaller HME providers, expansion into new geographic markets, and investment in telehealth solutions.
Summary
AdaptHealth Corp. is a major player in the HME market showing continuous growth through acquisitions. While revenue is growing, integration risks and debt remain key challenges. Solid cash flow and strategic initiatives support long-term growth potential. They should watch out for regulatory changes and growing competition.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Industry Reports
- Analyst Estimates
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Adapthealth Corp
Exchange NASDAQ | Headquaters Plymouth Meeting, PA, United States | ||
IPO Launch date 2018-05-24 | CEO & Director Ms. Suzanne M. Foster M.P.H. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 10500 | Website https://adapthealth.com |
Full time employees 10500 | Website https://adapthealth.com | ||
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.